Navigation Links
Cleveland Clinic Children's Hospital launches study to genetically test for autism
Date:2/29/2012

Wednesday, Feb. 29, 2012, Cleveland: Cleveland Clinic Children's Hospital has launched a study to determine whether genetic markers can be used to help identify children who are at risk of developing autism.

The study is designed to confirm the predictive value of established genetic markers and is a follow-up to retrospective studies that have been completed.

Thomas Frazier, Ph.D., of Cleveland Clinic Children's Hospital Center for Autism, is the principle investigator for the study being funded by IntegraGen, a French biomedical company. The study will enroll 600 children over the next two years.

"This is the first time anyone has done a prospective study on a combination of genetic markers to examine whether a genetic risk score is helpful in identifying children with autism," Dr. Frazier said. "Autism is currently assessed by looking at behavioral characteristics of children. If we can develop a genetic test to assist in the earlier diagnosis of autism, we can provide beneficial treatment that leads to improved outcomes more quickly."

This study launches as the autism community prepares for the American Psychiatric Association's publication of the fifth edition of Diagnostic and Statistical Manual of Mental Disorders (DSM-5) in May 2013. Many experts expect the DSM will have a huge impact on autism spectrum disorders by narrowing the criteria for autism, eliminating Asperger syndrome and PDD-NOS (Pervasive Developmental Disorder-Not Otherwise Specified).

"A genetic risk assessment tool has the potential to ensure that high-functioning individuals, who are part of the autism spectrum, continue to be appropriately identified and receive necessary treatments," Dr. Frazier said.

Dr. Frazier's team will also study whether genetic changes may be associated with attention deficit/hyperactivity disorder. The study will enroll 300 children between the ages of 1 and 12 who are suspected to have an autis
'/>"/>

Contact: Maureen Nagg
naggm@ccf.org
216-444-5703
Cleveland Clinic
Source:Eurekalert

Page: 1 2

Related biology news :

1. Cleveland Clinic joins 23andMe in the search for genetic clues to Parkinsons disease
2. Cleveland Clinic, Case Western Reserve University form research consortium
3. Cleveland Clinic researcher discovers genetic cause of thyroid cancer
4. Cleveland Clinic study discovers new targets for treating inflammatory, autoimmune diseases
5. Ohio Third Frontier awards $2.5 million for imaging research in Cleveland
6. Cleveland researchers collaborate to launch Phase 1 clinical trial for new MS treatment
7. Radiation from Japan detected in Cleveland
8. Cleveland Clinic researchers honored for contributions to science and technology
9. Draft sequence of Neandertal genome wins the 2010 AAAS Newcomb Cleveland Prize, supported by Affymetrix
10. Cleveland Museum of Natural History scientist announces new horned dinosaur
11. Cleveland Clinic, CWRU dental researcher finds switch that turns on the spread of cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/6/2015)... Calif. , Aug. 6, 2015  Today, ... will visit Crossmatch ™ to learn firsthand ... and protect data. Crossmatch is a world leader ... technologies and expertise are helping federal agencies and ... and security.   "The vast majority ...
(Date:8/5/2015)... , Aug. 5, 2015 The biosensors market ... in applications, penetration into newer sectors, and development of ... global biosensors space has seen the entry of multiple ... so far. (Photo - http://photos.prnewswire.com/prnh/20150805/255570 ) ... Analysis of the Global Biosensors Market ( ...
(Date:7/31/2015)... de julio de 2015 BGI llevará a cabo ... del 22 al 25 de octubre de 2015, en ... conferencia celebra su décimo aniversario este año. Desde su ... de las reuniones anuales más influyentes del mundo en ... las conferencias científicas más dinámicas, entusiastas y amenas. ...
Breaking Biology News(10 mins):Rep. Honda to Visit Crossmatch in Redwood City 2Innovative Biosensors Incite Use in Non-Traditional Applications 2Innovative Biosensors Incite Use in Non-Traditional Applications 3Innovative Biosensors Incite Use in Non-Traditional Applications 4La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 3
... protect nerves are the likely origin of the Devil Facial ... population, an international team of scientists has discovered. ... affects only Tasmanian devils and was first reported in 1996. ... The disease is characterised by large tumours, mostly on the ...
... FL Scientists from The Scripps Research Institute have ... infectious protein devoid of DNA or RNA that can ... The study from Scripps Florida in Jupiter ... at the protein level and, through natural selection, these ...
... in the remains of long-dead plants, animals, or humans allows ... studies of this kind on ancestral members of our own ... ancient DNA from modern-day human DNA contamination. Now, research by ... Leipzig, published online on December 31st in Current Biology ...
Cached Biology News:Nervous culprit found for Tassie devil facial tumor disease 2Scripps Florida scientists show 'lifeless' prions capable of evolutionary change and adaptation 2Scripps Florida scientists show 'lifeless' prions capable of evolutionary change and adaptation 3Scripps Florida scientists show 'lifeless' prions capable of evolutionary change and adaptation 4Using modern sequencing techniques to study ancient modern humans 2
(Date:8/31/2015)... SAN DIEGO , Aug. 31, 2015 ... drug development company announces that the Company,s lead antibody, ... subject of five separate presentations during the upcoming World ... Hawaii September 2-5, 2015. Researchers from the ... (MSK) will present results on the use of MabVax,s ...
(Date:8/31/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/k6lcp2/mexico_biomedical ) ... Sensors Market - Growth, Trends & Forecasts (2014-2020)" ... Mexico Biomedical Sensors market is estimated at $0.20 billion ... period 2014-2020 The near future will bring ... of each individual. These sensors can be set to ...
(Date:8/31/2015)... Research and Markets ( http://www.researchandmarkets.com/research/cbgl72/middle_east_and ) has announced the ... Sensors Market - Growth, Trends & Forecasts (2014-2020)" ... Middle East & Africa Biomedical Sensors ... a CAGR of 3.26% over the period 2014-2020 ... are adaptable to the genetic formulation of each individual. ...
(Date:8/31/2015)... Portage Biotech Inc. ("Portage" or "the Company") (OTC Market: ... that its wholly owned subsidiary, Portage Pharmaceuticals Ltd. (PPL) ... Investigational New Drug (IND) application for the topical treatment ... a study in a rat model of dry eye ... and a more rapid onset of action than 0.1% ...
Breaking Biology Technology:MabVax Therapeutics HuMab 5B1 Antibody Is Highlighted at Upcoming World Molecular Imaging Congress in Five Separate Presentations 2MabVax Therapeutics HuMab 5B1 Antibody Is Highlighted at Upcoming World Molecular Imaging Congress in Five Separate Presentations 3MabVax Therapeutics HuMab 5B1 Antibody Is Highlighted at Upcoming World Molecular Imaging Congress in Five Separate Presentations 4Mexico Biomedical Sensors Market Report 2015-2020 2Middle East & Africa Biomedical Sensors Market Report 2015 - Growth, Trends & Forecasts to 2020 2Portage's PPL will advance its lead candidate PPL-003 to an IND for dry eye disease and uveitis 2Portage's PPL will advance its lead candidate PPL-003 to an IND for dry eye disease and uveitis 3
... CALGARY, Nov. 29 /PRNewswire-FirstCall/ - Oncolytics Biotech ... Coffey, Chief,Scientific Officer of Oncolytics, is scheduled ... 2007 entitled "Large Scale Production Process for,the ... Informa Life,Sciences, 3rd Annual Vaccine Production Conference ...
... properties of a commonly used blue dye could revolutionise ... Advanced Materials. , Scientists have demonstrated that they can ... Phthalocyanine, or MPc, with the use of magnetism. ... researchers claim that the ability to control the magnetic ...
... Calif., Nov. 28 Bionovo, Inc.,(Nasdaq: BNVI ), a ... in the areas of women,s health and cancer, is scheduled ... Conference., The presentation by Tom Chesterman, SVP and CFO ... at 1:30 p.m. local time at the,Millennium Broadway Hotel in ...
Cached Biology Technology:Oncolytics Biotech Inc. to Present at Annual Vaccine Production Conference 2Blue dye could hold the key to super processing power 2Blue dye could hold the key to super processing power 3
... Timp-4 has been reported in heart ... fibroblasts in cell culture conditions. ... TPA stimulates production of TIMP-4 in ... protein levels produced often require concentration ...
Goat polyclonal to HSPC150 ( Abpromise for all tested applications). entrezGeneID: 29089...
Anti-MMP-13 Collagenase-3, amino terminal end of active enzyme; rabbit host...
...
Biology Products: